Jane Street Group, LLC Takeda Pharmaceutical CO LTD Call Options Transaction History

Jane Street Group, LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 17, 2022	SELL	$13.54 - $15.35 $10.8 Million - $12.2 Million	-797,000 Reduced 81.03%	186,600 $2.68 Million
Q4 2021 Feb 15, 2022	SELL	$13.17 - $16.4 $1.2 Million - $1.5 Million	-91,400 Reduced 8.5%	983,600 $13.4 Million
Q3 2021 Nov 16, 2021	BUY	$16.3 - $17.26 $16 Million - $16.9 Million	981,300 Added 1047.28%	1,075,000 $17.9 Million
Q2 2021 Aug 16, 2021	SELL	$16.55 - $18.64 $1.6 Million - $1.8 Million	-96,400 Reduced 50.71%	93,700 $1.57 Million
Q1 2021 May 18, 2021	BUY	$16.71 - $19.9 $1.19 Million - $1.41 Million	71,000 Added 59.61%	190,100 $3.42 Million

Q4 2020 Feb 17, 2021	BUY	$15.39 - $18.97 $977,265 - $1.2 Million	63,500 Added 114.21%	119,100 $2.17 Million
Q3 2020 Nov 17, 2020	SELL	$17.1 - $19.19 $275,310 - $308,959	-16,100 Reduced 22.45%	55,600 $987,000
Q2 2020 Aug 17, 2020	BUY	$14.59 - $19.5 $1.05 Million - $1.4 Million	71,700 New	71,700 $1.28 Million

341

76M

1.85M

121K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $40.5B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.